Front Range Bio Acquires Hemp Genomics Co. Steep Hill

Front Range Biosciences, an agricultural biotech company that specializes in high-value crops like cannabis and hemp, announced this week its acquisition of Steep Hill’s Genomics Research & Development team.

Through this partnership, FRB will further build out its IP library and accelerate key research in the pursuit of healthy and dependable crop yields. Ultimately, this allows FRB to continue providing unique and advantaged cannabis and hemp varieties to farmers and growers, further supporting the industrial hemp market, which is projected to hit $20 billion in 2024.

“To partner with an esteemed group like Steep Hill represents a pivotal moment in our company’s life cycle, as well as the industry overall,” said Dr. Jonathan Vaught, CEO and Co-Founder of FRB. “The more leaders we can have come together and collaborate for the advancement of the space, the better.”

Related Links:

Big Opportunities: Michigan Cannabis Market 'Could Easily Eclipse $2B'

Green Peak Joins Forces With Michigan-Based Short's Brewing To Create Cannabis-Infused Beer, Edibles

Posted In: CannabisM&ANewsMarketsFront Range Biosciences

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!